RNS Number : 9596C
MJ Gleeson PLC
22 October 2020

22 October 2020

MJ Gleeson Plc

("the Company")

Notification of Transaction by Directors/PDMRs

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was notified on 22 October 2020 that Leanne Johnson, the Company Secretary, being the Persons Discharging Management Responsibilities ("PDMR") acquired 498 Ordinary shares in the Company in London on 22 October 2020 at a purchase price of �5.452 per Ordinary Share.

This information set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Leanne

b)

Last Name

Johnson

2.

Reasons for the notification

a)

Position / status

Company Secretary

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of �0.02 each


GB00BRKD9Z53

b)

Nature of the transaction

Acquisition of shares.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

�5.452 per share

498 shares

d)

Aggregated information

-����� Aggregated volume

-����� Price

e)

Date of the transaction

22 October 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Enquiries:

Leanne Johnson����������������������

Company Secretary

MJ Gleeson plc����������������������������������� ����������������������������������� ������ Tel: 01142 612900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHMTBJTMTATBLM